Biotronik said today that new data from a European patient registry strengthen the clinical evidence for its Magmaris resorbable scaffold device, its procedure success and safety profile. The target lesion failure (TLF) rate at 12 months was 4.7%. Cardiac death occurred in 0.1% of the 800 patients who received Magmaris and scaffold thrombosis in 0.6%. […]
EuroPCR 2019: Elixir Medical touts DynamX
Elixir Medical touted clinical and imaging results from a study of its DynamX drug-eluting stent, which is designed to restore normal pulsatility and adaptive remodeling in blood vessels after treating a coronary lesion. DynamX, introduced in 2017 at the annual Transcatheter Cardiovascular Therapeutics meeting, is a cobalt-chromium stent with a biodegradable polymer coating that releases novolimus. […]
EuroPCR 2019: Medtronic touts three-year registry data for Symplicity RDN
Medtronic (NYSE:MDT) this week presented three-year data from a registry study of its Symplicity renal denervation device for treating high blood pressure. Results from the 2,600-patient trial, which has 2,300 patients past the three-year mark, showed that ablation of nerves lining the renal arteries lowered in-office blood pressure measurements by 16.5mm Hg and cut ambulatory blood […]
